40th Annual New Treatments in Chronic Liver Disease

40th Annual New Treatments in Chronic Liver Disease is organized by Scripps Conference Services & CME and will be held from Mar 14 - 15, 2026 at The Seabird Ocean Resort & Spa, a Destination by Hyatt Hotel, Oceanside, California, United States of America.

Description:
New Treatments in Chronic Liver Disease will explore the most recent advancements in medications and therapies for liver treatment and transplantation. It will provide an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. Our annual CME conference provides a comprehensive, yet focused program aimed at equipping physicians with the latest updates on these and other common challenges in the management of liver diseases.

Objectives:
After attending this live activity, participants should be able to:

• Cite new strategies for identifying and managing metabolic liver disease.
• Review updated goals and guidelines for curing Delta Hepatitis, HBV and HCV.
• Discuss potential new treatments for alcohol related liver disease.
• Summarize novel markers and therapies in PBC and PSC.
• Evaluate liver masses and new therapeutic options for HCC.
• Employ strategies for treating and managing ascites and hepatorenal syndrome.